European Journal of Gynaecological Oncology. 2026; 47(3): 136-136. doi: 10.22514/ejgo.2026.040
Correction

Correction: Prognostic value of Ki-67 in patients with ovarian cancer

Su Wan1,2, Chang Su1, Yong Wang3, Jin Ding1, Qingya Jiang1, Huafeng Ding1,*,, Guantai Ni1,*,

1Department of Obstetrics and Gynecology, The First Affiliated Hospital of Wannan Medical College, 241000 Wuhu, Anhui, China

2Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Soochow University, 215000 Suzhou, Jiangsu, China

3Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wannan Medical College, 241000 Wuhu, Anhui, China

*Corresponding Author(s):niguantai@yjsyy.com (Guantai Ni); dinghuafeng@wnmc.edu.cn (Huafeng Ding)

History Published: 15 October 2026
Copyright:  ©2026 The Author(s). Published by MRE Press.
This is an open access article under the CC BY 4.0 license (https://creativecommons.org/licenses/by/4.0/).

Collapse table of contents

Abstract

No abstract available.

Keywords:None.
PDF(227.38 kB)|EndNote (RIS)|BibTeX|RefMan|RefWorks

Cite this article

Su Wan, Chang Su, Yong Wang, Jin Ding, Qingya Jiang, Huafeng Ding, Guantai Ni. Correction: Prognostic value of Ki-67 in patients with ovarian cancer. European Journal of Gynaecological Oncology. 2026; 47(3): 136-136. doi: 10.22514/ejgo.2026.040

In the original publication [1], the following citation issues were identified: Reference 13 was a duplicate of Reference 9, Reference 20 was a duplicate of Reference 16, and References 13 and 20 had weak relevance to the corresponding discussions in the article. The authors made the following corrections to this article:

Reference 13 should read:

[13] Mita S, Nakai A, Maeda S, Takeshita T. Prognostic significance of Ki-67 antigen immunostaining (MIB-1 monoclonal antibody) in ovarian cancer. Journal of Nippon Medical School. 2004; 71: 384–391.

Reference 20 should read:

[20] Gaglia G, Kabraji S, Rammos D, Dai Y, Verma A, Wang S, et al. Temporal and spatial topography of cell proliferation in cancer. Nature Cell Biology. 2022; 24: 316–326.

The authors confirm that these corrections do not affect the scientific conclusions or the overall validity of the article. The authors apologize for any inconvenience caused.

References

Wan S, Su C, Wang Y, Ding J, Jiang QY, Ding HF, et al. Prognostic value of Ki-67 in patients with ovarian cancer. European Journal of Gynaecological Oncology. 2025; 46: 76–81.

[Google Scholar]